Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1%

Clinical trial NCT05461456 · COMPLETED

Trial details

NCT number: NCT05461456
Sponsor: OrchestratePharma GmbH
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Atopic Dermatitis Atopic Dermatitis Eczema Atopic Rash Rash Pruritus Urticaria Urticaria Chronic Psoriasis Psoriasis Vulgaris Skin Rash Skin Inflammation Eczema

Start date: 2022-04-01
Primary completion: 2022-10-16
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.